INTRODUCTION
Parkinson's disease (PD) is a common neurodegenerative disorder with motor impairment and nonmotor manifestations that result in progressive disability with a significant impact on patients' quality of life (QoL).
1,2
Traditionally, life expectancy was considered one of the key indicators for PD patients' health. However, it has been recognized that this indicator did not provide any information about the quality of the physical, mental, and social domains of life, the overall quality of life, a multidimensional construct including subjective assessments. 3, 4 On the other hand, when we refer to quality of life in the context of health and disease we usually use the term 'health related Revista Científica da Ordem dos Médicos www.actamedicaportuguesa.com quality of life' (HRQoL) in order to distinguish it from other aspects of quality of life. 2, 3 Indeed, the concept of HRQoL encompasses all the aspects of the overall quality of life that can have consequences on the individual health status, well-being and life satisfaction. 5 In the past years, the interest in health status instruments in PD has increased, as it can contribute to a better understanding of the disease's mainly affected areas and therapeutic interventions benefit as well as to better clinical decisions. However, to obtain an extensive and reliable picture remains difficult. 2, 6 Several HRQoL generic and specific scales have been used in PD patients. 1, 6, 7 Both 39-item Parkinson's Disease Questionnaire (PDQ-39) and Parkinson's Disease Quality of Life questionnaire (PDQL) were classified as recommend for use in PD by The Movement Disorder Society Task Force. 1, 8, 9 Since issues of HRQoL became a major concern for patient counselling, several validation studies for these scales have been published. [10] [11] [12] [13] [14] [15] However, despite PDQ-39 and PDQL were frequently used in current clinical practice, these scales were not validated for the particular Portuguese socio-cultural setting, which may have limited the correct interpretation of the scores previously obtained.
Therefore, we focused this paper on the validation process of the Portuguese versions of PDQ-39 and PDQL, evaluating their reliability and validity for use in clinical practice and research among Portuguese PD patients.
MATERIAL AND METHODS

Study design
Psychometric validation study to evaluate reliability and validity of the Portuguese version of PDQ-39 and PDQL measurement instruments. 8, 9 The present study proceeded in two phases. The first phase -cross-cultural adaptation -followed the sequential approach, commonly used in these type of studies, to obtain linguistically equivalent versions of the original PDQ-39 and PDQL. 16, 17 Semantic equivalence was achieved by two independent translations into Portuguese performed by two Portuguese bilingual experts, a consensus version, followed by a final backward translation performed by another translator, native in English and fluent in Portuguese.
The quality analysis of the translations and the first content validity were checked by a clinician review and in a cognitive debriefing panel with 10 patients with PD. After filling the questionnaires, each participant was asked to point out any difficulties in understanding or ambiguities in the translation. Both questionnaires were then tested for acceptability, understandability, ambiguity and redundancy. This stage completed the creation of the Portuguese versions of both PDQ-39 and PDQL.
The second phase of this study examined the reliability and validity tests of the Portuguese versions. Reliability was assessed by evaluating internal consistency and reproducibility. Internal consistency or homogeneity of data of a domain or scale is the extent to which their data define different aspects of the same attribute and was calculated for each domain. 18 On the other hand, reproducibility (testretest reliability) is the capacity of the instrument, in stable conditions, to reproduce the same results obtained from an initial evaluation 18 and was performed by applying the PDQ-39 and PDQL in two different times (10 to 12 days apart) to a sample of 13 patients not belonging to the initial sample. The following hypothesis was stated: H1 -Both PDQ-39 and PDQL have acceptable reliability.
Construct validity was tested by comparing the measure scores among known group variables. This type of validity verifies the capacity of the instrument to discriminate among subgroups of patients in different clinical states and was determined by comparing the PDQ-39 and PDQL scores among the groups of patients in different phases of the disease. Therefore, the following hypothesis was stated: H2 -The average scores from PDQ-39 and PDQL are different upon the disease's stages.
Criterion validity determines the amount of association between measures of the same construct, comparing the PDQ-39 and PDQL with each other and to a logically related generic measure instrument. So, the following hypothesis were stated: H3 -When PDQ-39 and PDQL scores are compared to SF-36 scores, similar domains are correlated; and H4 -PDQ-39 and PDQL measure similar quality dimensions.
Participants
Patients with clinical diagnosis of PD according to the Queen Square Brain Bank UK PDS Brain Bank Criteria for the diagnosis of PD 19 were consecutively recruited from the Neurology Department movement disorder outpatient clinic. Before inclusion of patients in this study, Mini Mental State Examination (MMSE) was performed to evaluate their cognitive state. 20 A cognitive deficit, translated by a MMSE of ≤ 15 if illiterate patient, ≤ 22 if patient with 1 -11 years of education or ≤ 27 if patient with educational level higher than 11 years, was an exclusion criteria. 20 Sociodemographics and clinical characteristics including age, gender, education, employment status and disease status according to modified Hoehn and Yahr scale (mH&Y) 21 were assessed. Both PDQ-39 and PDQL were filled by patients on a scheduled visit to the clinic. In case of comorbidities that prevent patient self-assessment, an informal carer assisted the patient in completing the form. For patients with fluctuations, measurements were applied to an 'on' status.
Instruments
The PDQL is composed of 37 items grouped into four subscales: parkinsonian symptoms (14 items), systemic symptoms (seven items), social function (seven items), and emotional function (nine items). 8 Item scores range from 1 (always) to 5 (never). A summary index is computed by averaging all scores for each dimension, ranging from 37 to 185, with higher scores reflecting better HRQoL.
The PDQ-39 is composed of 39 items grouped in eight subscales: mobility (10 items), activities of daily living (six items), emotional well-being (six items), stigma (four items), social support (three items), cognitions (four items), communication (three items), and bodily discomfort (three items).
9 Each item ranges from 0 (never) to 4 (always). Subscale scores and a summary index representing the global HRQoL may also be calculated (0-100), with higher scores representing worse HRQoL.
The Short Form 36-item Health Survey (SF-36) with 36 items is a generic measure of health status leading to eight major health dimensions (physical function, role limitations due to physical or emotional problems, intensity and the discomfort caused by pain, general health, vitality, social function and mental health), all of them on a scale of 0 -100, with the extreme anchors corresponding, respectively, to death and perfect health status. 22 In this study, the Portuguese version of the SF-36 was used.
23,24
Statistical analysis
Descriptive statistics were applied to demographic, rating scales and questionnaire data. Internal consistency reliability was tested by computing the Cronbach's alpha indicator. Scores between 0.70 and 0.95 are considered as acceptable realibility indicators. 25 The test-retest reliability was tested by the intraclass correlation coefficient (ICC), formula 2.1. A ICC greater or equal to 0.70 was considered positive. 25 PDQ-39 and PDQL's criteria validity was tested by comparing with each other and with the corresponding scores produced by SF-36. Pearson's correlation coefficients were computed following the same criteria as above. A p value less than 0.05 indicated statistical significance.
Ethics
Information about the research was given to all participants who were asked to sign a written informed consent for study participation. The study protocol and ethics procedures were approved by the Ethical Board of our institution.
RESULTS
Sample
From a total of 100 PD patients, 58% were female and the mean age was 65.8 (± 9.1) years. The mean score of MMSE was 24.9 (± 3.6) and the median score of mH&Y was 2.0 (interquartile range 1.0). Table 1 shows the main characteristics of the sample.
Analyzing the global scores for the eight domains of the PDQ-39, mobility and emotional well-being were the more affected areas. In PDQL, systemic symptoms was the more 
affected domain. Table 2 shows the mean scores and the corresponding standard deviations for the different domains of PDQ-39 and PDQL.
Reliability
Considering internal consistency, Cronbach's alpha for PDQ-39 ranged from 0.66 (bodily discomfort) to 0.98 (social support). Six dimensions (mobility, activities of daily living, emotional well-being, social support, cognitions and communication) met the standard for an acceptable reliability (> 0.70). On the other hand, the other two dimensions showed scores > 0.65. For the PDQL, Cronbach's alpha ranged from 0.78 (emotional function) to 0.98 (parkinsonian symptoms), all the dimensions exceeding 0.70.
On the other hand, test-retest scores for PDQ-39 and PDQL yielded statistically significant results. ICC for PDQ-39 ranged from 0.49 (bodily disconfort) to 0.96 (social support); stigma and bodily discomfort were not considered positive. Considering PDQL, ICC ranged from 0.65 for emotional function to 0.96 for parkinsonian symptoms. All dimensions, generally, met the standard criteria. Therefore, considering hypothesis H1, we may say that both measurement instruments are, in general, reliable. Almost all minimum standards were met, and the few exceptions were very close to the minimum standard. Table 3 shows the mean scores for each dimension according to the disease stage and the ANOVA analysis. Last column of this table presents the results of the Scheffe post-hoc test for pairwise comparisons.
Validity
To assess the PDQ-39's construct validity, five dimensions (mobility, activities of daily living, cognitions, communication and bodily discomfort) were able to distinguish patients at different mH&Y stages. For the two former dimensions, PDQ-39 was able to distinguish from initial to moderate and from moderate to advanced disease stages (represented in table 3 as 1 < 2 < 3); however, the last three dimensions, being able to distinguish between moderate and advanced stages, were not able to distinguish between initial and moderate stages (1 = 2 < 3). Also for PDQL, there was a significant difference in QoL scores between groups according to the stage of disease determined by the mH&Y. In the total PDQL and in both symptoms dimensions, the scores in initial stage are higher than in moderate stage, and in this stage are also higher than in advanced stage (1 > 2 > 3). In the emotional function dimension there is evidence of statistical difference between the initial and the advanced stages but, no strong differences between the two intermediate gaps (1 = 2 = 3) . Finally, for social function, PDQL was able to distinguish from the initial and the moderate stages but failed to distinguish between moderate and advanced stages (1 > 2 = 3). Therefore, taking into account hypothesis H2, we may state that, in general, both PDQ-39 and PDQL are able to distinguish among the disesase stages defined by mH&Y. Major exceptions are the domains emotional well-being, stigma and social support for PDQ-39.
To assess criterion validity we correlated PDQ-39 and PDQL scores with those from a generic health status measurement scale, the SF-36. Table 4 presents the correlation matrix obtained as well as the significance values.
Comparing PDQ-39 and SF-36, we found strong correlations between mobility and physical function, and between emotional well-being and mental health. We also found moderate correlations between activities of daily living and physical function, and between emotional wellbeing and vitality. In what concerns the comparison between PDQL and SF-36, strong correlations were only found between parkinsonian symptoms and physical function. However, moderate correlations were found between parkinsonian symptoms and physical role, vitality and emotional role; between systemic symptoms and physical functioning, physical role, vitality and emotional role; between emotional function and physical role, emotional role and mental health; and between social function and physical functioning, physical role and emotional role. Considering hypothesis H3, we may defend that although the scales presented moderate to strong magnitude 
DISCUSSION
Our results suggest that Portuguese PDQ-39 and PDQL, in spite of measuring different aspects of HRQoL, are both reliable and valid instruments. Indeed, Cronbach's alpha coefficients for most domains of PDQ-39 were higher than 0.7; the exceptions were stigma and bodily discomfort domains. All the PDQL domains succeded in achieving the standard criteria. The instruments showed good reproducibility, as in general there were no significant variations in the scores obtained from the first and the second application. Once again, the exceptions were stigma and bodily discomfort domains for PDQ-39 and emotional function for PDQL. For the validity evaluation, we observed that the scales had the capacity to discriminate differences in HRQoL among patients in the initial, moderate, and advanced stages of PD in general, excluding the domains emotional well-being, stigma and social support for PDQ-39. Furthermore, correlating the domains of PDQ-39 and PDQL with SF-36, we obtained moderate to strong magnitude correlations between some similar domains of the scales.
Sociodemographic data of the evaluated patients were equivalent to the characteristics observed in other studies of validation of PDQ-39 and PDQL, with similar mean age and disease stage. 10, 11 The internal consistency of the Portuguese PDQ-39 dimensions was in general equivalent to that previously reported and indicative of acceptable reliability. 9, 11, 12 Although in previously reported data the internal consistency of the PDQ-39 social support dimension proved to be weak, in our study bodily discomfort appeared as the less consistent dimension. 7, 9, 11, 13, 26 Indeed, bodily discomfort has been shown to occasionally possess low internal consistency, which has been partially justified by the small number of items of this dimension and the length of the scale.
7,27-29 PDQL proved to have high internal consistency, with Cronbach's alpha coefficient for the majority of the domains slightly higher than those reported elsewhere. 8, 10, 14, 30 These differences are better attributed to differences in the socio-cultural characteristics of the sample and, perhaps, in the distinct grades of disease's severity. 10, 14 Also, analyzing test-retest for PDQ-39, once again stigma and bodily discomfort did not achieve the standard criteria, suggesting that these dimensions may not provide accurate data. However, in other studies, the social support has been pointed as a weak domain. 7, 15, 31 The remaining dimensions scores agreed to those previously reported. 12, 27 Overall PDQL dimensions met the standard 27 The evaluation of reproducibility performed by Campos et al, using Mann-Whitney test, reported no statistically significant differences between the average scores of the two PDQL applications (Table 6) . 10 In the evaluation of the construct validity of the PDQ-39, most of the dimensions were able to discriminate patients at different mH&Y stages, with scores trending in the right direction, as the majority of the scores increased with mH&Y stages. The major exceptions were emotional well-being, stigma and social support, all of them previously reported in other studies as non significant.
11,15,31 Some authors defended that theses domains were not greatly influenced by disease severity in PD patients. 11, 32 For PDQL all the domains demonstrated significant differences among the stages of the disease. Analysing pairwise comparisons, parkinsonian symptoms and systemic symptoms, had lower scores as the disease advanced, corroborating previously reported data. 10, 14 However, emotional function dimension was not able to distinguish between intermediate stages.
Considering PDQ-39 and SF-36 correlation, it is evident that the instruments address distinct quality of life dimensions in PD patients, in spite of moderate to strong magnitude correlations between similar domains were obtained, corroborating previous published studies. 15, 31, 33 PDQL and the established generic measure of health status (SF-36) presented mostly moderate magnitude correlations between similar domains, agreeing with the results presented by Boer et al. 8 On the other hand, comparing PDQ-39 and PDQL scores we evidence that both instruments deal with some different aspects of HRQoL, although showing moderate to strong correlations between some of their dimensions. Our results are slightly different from those presented by Martinez-Martin et al concerning the magnitude of the correlations and the similarity between dimensions involved, but we have to take in consideration the distinct sample size as well as demographic characteristics (gender, age and disease stage) and that different cut-off values were defined to establish significant magnitude correlations. 27 Our study has limitations that need to be taken under consideration in its analysis. Firstly, the sample size restricts the extrapolation of the results to other environments. Secondly, the majority of our patients had a moderate stage of the disease, which influence the PDQ-39 results and limit generalizability to other phases of the disease. Furthermore, we have to consider the small sample of patients used in test-retest reliability. However, it is important to consider that test-retest reliability was performed in stable conditions and patients were instructed to document any alteration in their disease state between the two moments of evaluation; significant changes in their disease severity were excluded. Also the time frame used is considered to be small and our results demonstrated, in general, high magnitude values for ICC.
CONCLUSION
The current study supports the application of the Portuguese versions of PDQ-39 and PDQL in clinical practice and research studies that assess HRQoL in PD patients. Indeed, the majority of our results addressing the reliabity and the validity of these instruments met the standard criteria. Regarding the less positive results, we have to consider the socio-cultural context as well as the language particularities in their interpretation. We recommend the final user to look at the dimensions measured by each instrument in order to decide which one (or both) should implement in their PD patients.
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